Reuters -- Abraxane, a new cancer drug designed to be less toxic than standard chemotherapy, did a better job of keeping cancer at bay in women whose breast cancer had spread, U.S. researchers said on Tuesday.
Reuters -- Abraxane, a new cancer drug designed to be less toxic than standard chemotherapy, did a better job of keeping cancer at bay in women whose breast cancer had spread, U.S. researchers said on Tuesday.
